ARTICLE | Company News
Carrington, National Institutes of Health deal
May 26, 2008 7:00 AM UTC
Carrington’s DelSite Biotechnologies Inc. subsidiary extended a license to evaluate NIH’s polysaccharide technology’s ability to create a typhoid vaccine with DelSite’s GelSite delivery polymer. Terms...